QL
ACAD icon

Quarry LP’s Acadia Pharmaceuticals ACAD Stock Holding History

Quarry LP’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
50,155
+35,155
+234% +$773K 0.11% 76
2026
Q1 		$334K Sell
15,000
-1,000
-6% -$23.9K 0.06% 220
2025
Q4 		$427K Buy
16,000
+4,624
+41% +$110K 0.07% 171
2025
Q3 		$243K Buy
+11,376
New +$269K 0.05% 301
2025
Q2 		– Sell
-9,500
Closed -$158K – 1699
2025
Q1 		$158K Buy
+9,500
New +$173K 0.03% 360
2024
Q3 		– Sell
-8,055
Closed -$131K – 1589
2024
Q2 		$131K Buy
8,055
+2,055
+34% +$33.2K 0.04% 263
2024
Q1 		$111K Buy
+6,000
New +$149K 0.02% 220

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quarry LP's ACAD Position: Q2 2026 in Review

Quarry LP increased its Acadia Pharmaceuticals (ACAD) stake by 234% in Q2 2026, buying an estimated $773K and bringing the position to 50,155 shares worth $1.27M. The position accounts for 0.11% of the portfolio, ranked #76.

Quarry LP first reported a position in ACAD in Q1 2024 and has held it in 7 quarters since. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Quarry LP held 50,155 shares of Acadia Pharmaceuticals worth $1.27M as of Q2 2026.
  • Quarry LP bought 35,155 Acadia Pharmaceuticals shares in Q2 2026, an estimated $773K.
  • Acadia Pharmaceuticals made up 0.11% of Quarry LP's portfolio in Q2 2026, its #76 holding.
  • Quarry LP first reported a position in Acadia Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.